 | • レポートコード：GIR-107A12077 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、82ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、自己幹細胞治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。自己幹細胞治療の種類別市場規模（胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞）、用途別市場規模（神経変性疾患、自己免疫疾患、心血管疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・自己幹細胞治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Regeneus、Mesoblast、Pluristem Therapeutics Inc、US STEM CELL, INC.、Brainstorm Cell Therapeutics、Tigenix、Med cell Europe ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：胚性幹細胞、常在心臓幹細胞、臍帯血幹細胞 ・用途別分析2016年-2026年：神経変性疾患、自己免疫疾患、心血管疾患 ・自己幹細胞治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・自己幹細胞治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・自己幹細胞治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・自己幹細胞治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・自己幹細胞治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Autologous Stem Cell Based Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Autologous Stem Cell Based Therapies size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Autologous Stem Cell Based Therapies market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Autologous Stem Cell Based Therapies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Embryonic Stem Cell
Resident Cardiac Stem Cells
Umbilical Cord Blood Stem Cells
Market segment by Application, can be divided into
Neurodegenerative Disorders
Autoimmune Diseases
Cardiovascular Diseases
Market segment by players, this report covers
Regeneus
Mesoblast
Pluristem Therapeutics Inc
US STEM CELL, INC.
Brainstorm Cell Therapeutics
Tigenix
Med cell Europe
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Autologous Stem Cell Based Therapies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Autologous Stem Cell Based Therapies, with revenue, gross margin and global market share of Autologous Stem Cell Based Therapies from 2019 to 2021.
Chapter 3, the Autologous Stem Cell Based Therapies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Autologous Stem Cell Based Therapies market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Autologous Stem Cell Based Therapies research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Autologous Stem Cell Based Therapies
1.2 Classification of Autologous Stem Cell Based Therapies by Type
1.2.1 Overview: Global Autologous Stem Cell Based Therapies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Autologous Stem Cell Based Therapies Revenue Market Share by Type in 2020
1.2.3 Embryonic Stem Cell
1.2.4 Resident Cardiac Stem Cells
1.2.5 Umbilical Cord Blood Stem Cells
1.3 Global Autologous Stem Cell Based Therapies Market by Application
1.3.1 Overview: Global Autologous Stem Cell Based Therapies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Neurodegenerative Disorders
1.3.3 Autoimmune Diseases
1.3.4 Cardiovascular Diseases
1.4 Global Autologous Stem Cell Based Therapies Market Size & Forecast
1.5 Global Autologous Stem Cell Based Therapies Market Size and Forecast by Region
1.5.1 Global Autologous Stem Cell Based Therapies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Autologous Stem Cell Based Therapies Market Size by Region, (2016-2021)
1.5.3 North America Autologous Stem Cell Based Therapies Market Size and Prospect (2016-2026)
1.5.4 Europe Autologous Stem Cell Based Therapies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Autologous Stem Cell Based Therapies Market Size and Prospect (2016-2026)
1.5.6 South America Autologous Stem Cell Based Therapies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Autologous Stem Cell Based Therapies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Autologous Stem Cell Based Therapies Market Drivers
1.6.2 Autologous Stem Cell Based Therapies Market Restraints
1.6.3 Autologous Stem Cell Based Therapies Trends Analysis
2 Company Profiles
2.1 Regeneus
2.1.1 Regeneus Details
2.1.2 Regeneus Major Business
2.1.3 Regeneus Autologous Stem Cell Based Therapies Product and Solutions
2.1.4 Regeneus Autologous Stem Cell Based Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Regeneus Recent Developments and Future Plans
2.2 Mesoblast
2.2.1 Mesoblast Details
2.2.2 Mesoblast Major Business
2.2.3 Mesoblast Autologous Stem Cell Based Therapies Product and Solutions
2.2.4 Mesoblast Autologous Stem Cell Based Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Mesoblast Recent Developments and Future Plans
2.3 Pluristem Therapeutics Inc
2.3.1 Pluristem Therapeutics Inc Details
2.3.2 Pluristem Therapeutics Inc Major Business
2.3.3 Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Product and Solutions
2.3.4 Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pluristem Therapeutics Inc Recent Developments and Future Plans
2.4 US STEM CELL, INC.
2.4.1 US STEM CELL, INC. Details
2.4.2 US STEM CELL, INC. Major Business
2.4.3 US STEM CELL, INC. Autologous Stem Cell Based Therapies Product and Solutions
2.4.4 US STEM CELL, INC. Autologous Stem Cell Based Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 US STEM CELL, INC. Recent Developments and Future Plans
2.5 Brainstorm Cell Therapeutics
2.5.1 Brainstorm Cell Therapeutics Details
2.5.2 Brainstorm Cell Therapeutics Major Business
2.5.3 Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Product and Solutions
2.5.4 Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Brainstorm Cell Therapeutics Recent Developments and Future Plans
2.6 Tigenix
2.6.1 Tigenix Details
2.6.2 Tigenix Major Business
2.6.3 Tigenix Autologous Stem Cell Based Therapies Product and Solutions
2.6.4 Tigenix Autologous Stem Cell Based Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Tigenix Recent Developments and Future Plans
2.7 Med cell Europe
2.7.1 Med cell Europe Details
2.7.2 Med cell Europe Major Business
2.7.3 Med cell Europe Autologous Stem Cell Based Therapies Product and Solutions
2.7.4 Med cell Europe Autologous Stem Cell Based Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Med cell Europe Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Autologous Stem Cell Based Therapies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Autologous Stem Cell Based Therapies Players Market Share
3.2.2 Top 10 Autologous Stem Cell Based Therapies Players Market Share
3.2.3 Market Competition Trend
3.3 Autologous Stem Cell Based Therapies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Autologous Stem Cell Based Therapies Revenue and Market Share by Type (2016-2021)
4.2 Global Autologous Stem Cell Based Therapies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Autologous Stem Cell Based Therapies Revenue Market Share by Application (2016-2021)
5.2 Autologous Stem Cell Based Therapies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Autologous Stem Cell Based Therapies Revenue by Type (2016-2026)
6.2 North America Autologous Stem Cell Based Therapies Revenue by Application (2016-2026)
6.3 North America Autologous Stem Cell Based Therapies Market Size by Country
6.3.1 North America Autologous Stem Cell Based Therapies Revenue by Country (2016-2026)
6.3.2 United States Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
6.3.3 Canada Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
6.3.4 Mexico Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Autologous Stem Cell Based Therapies Revenue by Type (2016-2026)
7.2 Europe Autologous Stem Cell Based Therapies Revenue by Application (2016-2026)
7.3 Europe Autologous Stem Cell Based Therapies Market Size by Country
7.3.1 Europe Autologous Stem Cell Based Therapies Revenue by Country (2016-2026)
7.3.2 Germany Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
7.3.3 France Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
7.3.5 Russia Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
7.3.6 Italy Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Type (2016-2026)
8.2 Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Application (2016-2026)
8.3 Asia-Pacific Autologous Stem Cell Based Therapies Market Size by Region
8.3.1 Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Region (2016-2026)
8.3.2 China Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
8.3.3 Japan Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
8.3.4 South Korea Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
8.3.5 India Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
8.3.7 Australia Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Autologous Stem Cell Based Therapies Revenue by Type (2016-2026)
9.2 South America Autologous Stem Cell Based Therapies Revenue by Application (2016-2026)
9.3 South America Autologous Stem Cell Based Therapies Market Size by Country
9.3.1 South America Autologous Stem Cell Based Therapies Revenue by Country (2016-2026)
9.3.2 Brazil Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
9.3.3 Argentina Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Type (2016-2026)
10.2 Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Application (2016-2026)
10.3 Middle East & Africa Autologous Stem Cell Based Therapies Market Size by Country
10.3.1 Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Country (2016-2026)
10.3.2 Turkey Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
10.3.4 UAE Autologous Stem Cell Based Therapies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Autologous Stem Cell Based Therapies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Autologous Stem Cell Based Therapies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Autologous Stem Cell Based Therapies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Autologous Stem Cell Based Therapies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Autologous Stem Cell Based Therapies Revenue Market Share by Region (2021-2026)
Table 6. Regeneus Corporate Information, Head Office, and Major Competitors
Table 7. Regeneus Major Business
Table 8. Regeneus Autologous Stem Cell Based Therapies Product and Solutions
Table 9. Regeneus Autologous Stem Cell Based Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Mesoblast Corporate Information, Head Office, and Major Competitors
Table 11. Mesoblast Major Business
Table 12. Mesoblast Autologous Stem Cell Based Therapies Product and Solutions
Table 13. Mesoblast Autologous Stem Cell Based Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pluristem Therapeutics Inc Corporate Information, Head Office, and Major Competitors
Table 15. Pluristem Therapeutics Inc Major Business
Table 16. Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Product and Solutions
Table 17. Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. US STEM CELL, INC. Corporate Information, Head Office, and Major Competitors
Table 19. US STEM CELL, INC. Major Business
Table 20. US STEM CELL, INC. Autologous Stem Cell Based Therapies Product and Solutions
Table 21. US STEM CELL, INC. Autologous Stem Cell Based Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Brainstorm Cell Therapeutics Corporate Information, Head Office, and Major Competitors
Table 23. Brainstorm Cell Therapeutics Major Business
Table 24. Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Product and Solutions
Table 25. Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Tigenix Corporate Information, Head Office, and Major Competitors
Table 27. Tigenix Major Business
Table 28. Tigenix Autologous Stem Cell Based Therapies Product and Solutions
Table 29. Tigenix Autologous Stem Cell Based Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Med cell Europe Corporate Information, Head Office, and Major Competitors
Table 31. Med cell Europe Major Business
Table 32. Med cell Europe Autologous Stem Cell Based Therapies Product and Solutions
Table 33. Med cell Europe Autologous Stem Cell Based Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Autologous Stem Cell Based Therapies Revenue (USD Million) by Players (2019-2021)
Table 35. Global Autologous Stem Cell Based Therapies Revenue Share by Players (2019-2021)
Table 36. Breakdown of Autologous Stem Cell Based Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Autologous Stem Cell Based Therapies Players Head Office, Products and Services Provided
Table 38. Autologous Stem Cell Based Therapies Mergers & Acquisitions in the Past Five Years
Table 39. Autologous Stem Cell Based Therapies New Entrants and Expansion Plans
Table 40. Global Autologous Stem Cell Based Therapies Revenue (USD Million) by Type (2016-2021)
Table 41. Global Autologous Stem Cell Based Therapies Revenue Share by Type (2016-2021)
Table 42. Global Autologous Stem Cell Based Therapies Revenue Forecast by Type (2021-2026)
Table 43. Global Autologous Stem Cell Based Therapies Revenue by Application (2016-2021)
Table 44. Global Autologous Stem Cell Based Therapies Revenue Forecast by Application (2021-2026)
Table 45. North America Autologous Stem Cell Based Therapies Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Autologous Stem Cell Based Therapies Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Autologous Stem Cell Based Therapies Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Autologous Stem Cell Based Therapies Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Autologous Stem Cell Based Therapies Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Autologous Stem Cell Based Therapies Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Autologous Stem Cell Based Therapies Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Autologous Stem Cell Based Therapies Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Autologous Stem Cell Based Therapies Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Autologous Stem Cell Based Therapies Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Autologous Stem Cell Based Therapies Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Autologous Stem Cell Based Therapies Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Autologous Stem Cell Based Therapies Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Autologous Stem Cell Based Therapies Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Autologous Stem Cell Based Therapies Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Autologous Stem Cell Based Therapies Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Autologous Stem Cell Based Therapies Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Autologous Stem Cell Based Therapies Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Autologous Stem Cell Based Therapies Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Autologous Stem Cell Based Therapies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Autologous Stem Cell Based Therapies Picture
Figure 2. Global Autologous Stem Cell Based Therapies Revenue Market Share by Type in 2020
Figure 3. Embryonic Stem Cell
Figure 4. Resident Cardiac Stem Cells
Figure 5. Umbilical Cord Blood Stem Cells
Figure 6. Autologous Stem Cell Based Therapies Revenue Market Share by Application in 2020
Figure 7. Neurodegenerative Disorders Picture
Figure 8. Autoimmune Diseases Picture
Figure 9. Cardiovascular Diseases Picture
Figure 10. Global Autologous Stem Cell Based Therapies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Autologous Stem Cell Based Therapies Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Autologous Stem Cell Based Therapies Revenue Market Share by Region (2016-2026)
Figure 13. Global Autologous Stem Cell Based Therapies Revenue Market Share by Region in 2020
Figure 14. North America Autologous Stem Cell Based Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Autologous Stem Cell Based Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Autologous Stem Cell Based Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Autologous Stem Cell Based Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Autologous Stem Cell Based Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Autologous Stem Cell Based Therapies Market Drivers
Figure 20. Autologous Stem Cell Based Therapies Market Restraints
Figure 21. Autologous Stem Cell Based Therapies Market Trends
Figure 22. Regeneus Recent Developments and Future Plans
Figure 23. Mesoblast Recent Developments and Future Plans
Figure 24. Pluristem Therapeutics Inc Recent Developments and Future Plans
Figure 25. US STEM CELL, INC. Recent Developments and Future Plans
Figure 26. Brainstorm Cell Therapeutics Recent Developments and Future Plans
Figure 27. Tigenix Recent Developments and Future Plans
Figure 28. Med cell Europe Recent Developments and Future Plans
Figure 29. Global Autologous Stem Cell Based Therapies Revenue Share by Players in 2020
Figure 30. Autologous Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Autologous Stem Cell Based Therapies Revenue Market Share in 2020
Figure 32. Global Top 10 Players Autologous Stem Cell Based Therapies Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Autologous Stem Cell Based Therapies Revenue Share by Type in 2020
Figure 35. Global Autologous Stem Cell Based Therapies Market Share Forecast by Type (2021-2026)
Figure 36. Global Autologous Stem Cell Based Therapies Revenue Share by Application in 2020
Figure 37. Global Autologous Stem Cell Based Therapies Market Share Forecast by Application (2021-2026)
Figure 38. North America Autologous Stem Cell Based Therapies Sales Market Share by Type (2016-2026)
Figure 39. North America Autologous Stem Cell Based Therapies Sales Market Share by Application (2016-2026)
Figure 40. North America Autologous Stem Cell Based Therapies Revenue Market Share by Country (2016-2026)
Figure 41. United States Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Autologous Stem Cell Based Therapies Sales Market Share by Type (2016-2026)
Figure 45. Europe Autologous Stem Cell Based Therapies Sales Market Share by Application (2016-2026)
Figure 46. Europe Autologous Stem Cell Based Therapies Revenue Market Share by Country (2016-2026)
Figure 47. Germany Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Autologous Stem Cell Based Therapies Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Autologous Stem Cell Based Therapies Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Autologous Stem Cell Based Therapies Revenue Market Share by Region (2016-2026)
Figure 55. China Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Autologous Stem Cell Based Therapies Sales Market Share by Type (2016-2026)
Figure 62. South America Autologous Stem Cell Based Therapies Sales Market Share by Application (2016-2026)
Figure 63. South America Autologous Stem Cell Based Therapies Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Autologous Stem Cell Based Therapies Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Autologous Stem Cell Based Therapies Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Autologous Stem Cell Based Therapies Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Autologous Stem Cell Based Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
世界のヒト間葉系幹細胞（hMSC）市場 2021：企業別、地域別、種類・用途別 The Human Mesenchymal Stem Cells (hMSC) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 世界の幹細胞治療市場 2021：企業別、地域別、種類・用途別 The Stem Cell Treatments market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
- 世界の幹細胞用装置市場 2021：企業別、地域別、種類・用途別 The Stem Cell Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の成体幹細胞アッセイ市場 2021：企業別、地域別、種類・用途別 The Adult Stem Cell Assay market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の幹細胞＆初代細胞培養培地市場 2021：企業別、地域別、種類・用途別 The Stem Cell and Primary Cell Culture Medium market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…